Filing Details

Accession Number:
0001209191-21-045877
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-07 17:31:29
Reporting Period:
2021-07-06
Accepted Time:
2021-07-07 17:31:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891024 Patterson Companies Inc. PDCO Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) 410886515
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591945 L. Andrea Frohning 1031 Mendota Heights Road
St. Paul MN 55120
Chief Human Resources Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-07-06 77 $30.28 41,482 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,070 Indirect By ESOP
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Options $30.77 2031-07-01 17,339 17,339 Direct
Common Stock Employee Stock Options $23.57 2030-07-14 22,026 22,026 Direct
Common Stock Employee Stock Options $22.25 2029-07-01 30,030 30,030 Direct
Common Stock Employee Stock Options $22.48 2021-07-01 2028-07-01 10,009 10,009 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2031-07-01 17,339 17,339 Direct
2030-07-14 22,026 22,026 Direct
2029-07-01 30,030 30,030 Direct
2028-07-01 10,009 10,009 Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 31, 2021.
  2. Includes an aggregate of 14,541 RSUs awarded on 7/1/2018, 7/1/2019, 7/14/2020 and 7/1/2021 to Reporting Person pursuant to the Plan. The RSUs vest contingent upon continued employment as follows: 6,649 units vest 7/1/2022, 2,156 units vest 7/1/2023, 4,243 units vest 7/14/2023 and 1,493 units vest 7/1/2024.
  3. Includes 12,810 RSU equivalents attributable to the July 1, 2020 determination by the Compensation Committee that the performance criteria for the period of April 27, 2019 through April 25, 2020 applicable to non-derivative performance units issued on July 1, 2019 had been satisfied. Subject to continued employment of the Reporting Person through July 1, 2022, the restricted stock unit equivalents will automatically convert into shares of common stock.
  4. Represents shares of common stock indirectly held by Reporting Person's Employee Stock Ownership Plan ("ESOP") account through May 21, 2021.
  5. Stock options granted pursuant to the Plan on 7/1/2021.
  6. Options are exercisable as follows: 33.3% on 7/1/2022, 33.3% on 7/1/2023 and 33.4% on 7/1/2024.
  7. Stock options granted pursuant to the Plan on 7/14/2020.
  8. Options are exercisable as follows: 33.3% on 7/14/2021, 33.3% on 7/14/2022 and 33.4% on 7/14/2023.
  9. Stock options granted pursuant to the Plan on 7/1/2019.
  10. Options are exercisable as follows: 33.3% on 7/1/2020, 33.3% on 7/1/2021 and 33.4% on 7/1/2022.
  11. Stock options granted pursuant to the Plan on 7/1/2018.